Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MGAM | O43451 | 5/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28324472 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| Perseitol SCHEMBL9231331 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| Perseitol SCHEMBL6078816 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| Perseitol SCHEMBL11799710 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| SCHEMBL20838342 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| Perseitol SCHEMBL23832483 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| Perseitol SCHEMBL6078811 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| SCHEMBL22283330 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| Perseitol SCHEMBL20567548 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1PDE4AUSP2 | |
| SCHEMBL532838 | 0.84 | TDP1 (1.00) | TDP1LMNAL3MBTL1PDE4AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210094966-A1 | PROCESS FOR PRODUCING A FIVE-MEMBERED POLYCYCLOALIPHATIC CARBONATE | TEREOS STARCH & SWEETENERS BELGIUM (BE) | 2021-04-01 | — | — | US | disclosed |
| EP-3601248-A1 | PROCESS FOR PRODUCING A FIVE-MEMBERED POLYCYCLOALIPHATIC CARBONATE | Tereos Starch & Sweeteners Belgium (BE) | 2020-02-05 | — | — | EP | disclosed |
| CN-104661633-B | Cosmetic composition | 德之馨股份公司 | 2019-04-23 | — | — | CN | disclosed |
| WO-2018178362-A1 | PROCESS FOR PRODUCING A FIVE-MEMBERED POLYCYCLOALIPHATIC CARBONATE | TEREOS STARCH & SWEETENERS BELGIUM (BE) | 2018-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210094966-A1 | PROCESS FOR PRODUCING A FIVE-MEMBERED POLYCYCLOALIPHATIC CARBONATE | PUF60, PCK1, CA7 | TDP1 4052/4885LMNA 2940/4885L3MBTL1 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.